New clinical trial aims to tackle bowel cancer
Oxford University Hospitals has started a clinical trial which combines the use of immunotherapy with a protein-inhibiting drug for use with difficult-to-treat bowel cancer. Immunotherapy combined with checkpoint inhibitor drugs has been used successfully as treatment for several cancers, including melanoma and lung cancer, but until now has not worked so effectively on bowel cancer. […]